John C. Krauss
University of Michigan · 164 works · 8,877 citations · h-index 36
Top works
- KRAS G12C Inhibition with Sotorasib in Advanced Solid Tumors
- Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1–2 trials
- Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy
- Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 study
- Long-Term Results of Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy: The Randomized Phase II OPRA Trial
- Eliciting T Cell Immunity Against Poorly Immunogenic Tumors by Immunization with Dendritic Cell-Tumor Fusion Vaccines
- Correction of CD18-Deficient Lymphocytes by Retrovirus-Mediated Gene Transfer
- Monocyte chemoattractant protein inhibits the generation of tumor-reactive T cells.
- Sotorasib for previously treated colorectal cancers with KRASG12C mutation (CodeBreaK100): a prespecified analysis of a single-arm, phase 2 trial
- Reconstitution of antibody-dependent phagocytosis in fibroblasts expressing Fc gamma receptor IIIB and the complement receptor type 3.
- Rituximab Extended Schedule or Re-Treatment Trial for Low–Tumor Burden Follicular Lymphoma: Eastern Cooperative Oncology Group Protocol E4402
- Tubulogenesis from isolated single cells of adult mammalian kidney: clonal analysis with a recombinant retrovirus
- Strategies of Lymphocyte Activation for the Adoptive Immunotherapy of Metastatic Cancer: A Review
- Lack of plasminogen activator inhibitor-1 effect in a transgenic mouse model of metastatic melanoma.
- Diverse manifestations of tumorigenicity and immunogenicity displayed by the poorly immunogenic B16-BL6 melanoma transduced with cytokine genes
- Interaction of Fcγ receptor type IIIB with complement receptor type 3 in fibroblast transfectants: Evidence from lateral diffusion and resonance energy transfer studies
- Isolation based on L-selectin expression of immune effector T cells derived from tumor-draining lymph nodes.
- Phase II Evaluation of Gefitinib in Patients With Newly Diagnosed Grade 4 Astrocytoma: Mayo/North Central Cancer Treatment Group Study N0074
- Hematopoietic stem cell gene replacement therapy
- Systemic T cell adoptive immunotherapy of malignant gliomas